21 May 2026
LONDONMETRIC PROPERTY PLC (“LondonMetric” or the “Group” or the “Company”) FULL YEAR RESULTS FOR THE YEAR ENDED 31 MARCH 2026 Delivering reliable and growing…
20 May 2026
Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 19 May 2026 – Euronext, the leading European capital market infrastructure, today publishes its results for…
Caledonia Investments plc Final results for the year ended 31 March 2026 Financial highlights Year 31 March 2026 Year 31 March 2025 Net…
19 May 2026
CRANSWICK plc: PRELIMINARY RESULTS Strong strategic and financial progress driven by disciplined investment and operational excellence 19 May 2026 Cranswick plc (“Cranswick” or “the…
18 May 2026
HARWORTH GROUP PLC (‘Harworth’ or the ‘Group’ or the ‘Company’) AGM Statement Strategic I&L land position supports long-term value realisation Harworth Group plc, a…
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18-59 at increased risk · First RSV vaccine approved for adults aged 18-59 years at increased…
18 May 2026 Enhertu approved in the US for two new indications for patients with HER2-positive early breast cancer Approved for use before surgery based…
18 May 2026 Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension Approval based on BaxHTN Phase…